Merck KGaA (OTCMKTS:MKGAF) Hits New 1-Year Low – Should You Sell?

Merck KGaA (OTCMKTS:MKGAF)’s stock price reached a new 52-week low on Thursday . The stock traded as low as $142.05 and last traded at $142.05, with a volume of 228 shares traded. The stock had previously closed at $145.80.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group raised Merck KGaA to a “strong-buy” rating in a report on Thursday, September 19th.

Merck KGaA Stock Down 2.6 %

The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The stock has a market capitalization of $18.36 billion, a price-to-earnings ratio of 21.69 and a beta of 0.96. The business has a fifty day moving average of $157.53 and a 200 day moving average of $171.18.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.